Publication Name	World Journal of Gastroenterology
Manuscript ID	59118
Country	United States

Received	2020-08-31 17:11
Peer-Review Started	2020-08-31 17:12
To Make the First Decision
Return for Revision	2020-09-24 18:24
Revised	2020-10-24 19:40
Second Decision	2020-11-10 12:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-11-12 21:34
Articles in Press	2020-11-12 21:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-11-20 06:00
Publish the Manuscript Online	2020-11-27 09:27

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Emerging use of artificial intelligence in inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Arushi Kohli, Erik A Holzwanger and Alexander N Levy
ORCID	Author(s) ORCID Number Arushi Kohli http://orcid.org/0000-0002-9974-4821 Erik A Holzwanger http://orcid.org/0000-0001-7747-7729 Alexander N Levy http://orcid.org/0000-0002-6293-0380
Funding Agency and Grant Number
Corresponding Author	Alexander N Levy, MD, Assistant Professor, Attending Doctor, Division of Gastroenterology and Hepatology, Tufts Medical Center, 800 Washington Street, Box 233, Boston , MA 02111, United States. alevy@tuftsmedicalcenter.org
Key Words	Artificial intelligence; Machine learning; Automated diagnostics; Colorectal neoplasia screening; Multiomic data; Predictive models
Core Tip	Artificial intelligence (AI) is a novel technological advancement that is rapidly growing in the field of inflammatory bowel disease. The use of AI and machine learning has been shown to aid in diagnosing and understanding severity of disease, predicting treatment response along with likelihood of disease recurrence and assisting with colorectal neoplasia screening in this patient population. Further studies are needed to understand the full impact AI may have on improving Crohn’s disease and ulcerative colitis patient outcomes.
Publish Date	2020-11-27 09:27
Citation	Kohli A, Holzwanger EA, Levy AN. Emerging use of artificial intelligence in inflammatory bowel disease. World J Gastroenterol 2020; 26(44): 6923-6928
URL	https://www.wjgnet.com/1007-9327/full/v26/i44/6923.htm
DOI	https://dx.doi.org/10.3748/wjg.v26.i44.6923

Full Article (PDF)	WJG-26-6923.pdf
Full Article (Word)	WJG-26-6923.docx
Manuscript File	59118_Auto_Edited.docx
Answering Reviewers	59118-Answering reviewers.pdf
Audio Core Tip	59118-Audio core tip.wav
Conflict-of-Interest Disclosure Form	59118-Conflict-of-interest statement.pdf
Copyright License Agreement	59118-Copyright license agreement.pdf
Peer-review Report	59118-Peer-review(s).pdf
Scientific Misconduct Check	59118-Scientific misconduct check.pdf
Scientific Editor Work List	59118-Scientific editor work list.pdf